ProShare Advisors

ProShare Advisors’s Zevra Therapeutics ZVRA Stock Holding History

ProShare Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$98.7K	Sell	10,594 -2,075	-16%	-$18.7K	﹤0.01%	1707
2025 Q4	$114K	Buy	12,669 +1,390	+12%	+$13.1K	﹤0.01%	1850
2025 Q3	$107K	Sell	11,279 -1,892	-14%	-$19K	﹤0.01%	1831
2025 Q2	$116K	Sell	13,171 -851	-6%	-$6.91K	﹤0.01%	1852
2025 Q1	$105K	Sell	14,022 -3,403	-20%	-$27K	﹤0.01%	1825
2024 Q4	$145K	Buy	+17,425	New	+$149K	﹤0.01%	1977
2024 Q3	–	Sell	-4,871	Closed	-$23.9K	–	2125
2024 Q2	$23.9K	Buy	+4,871	New	+$23.1K	﹤0.01%	1802
2022 Q1	–	Sell	-11,452	Closed	-$100K	–	2312
2021 Q4	$100K	Buy	+11,452	New	+$102K	﹤0.01%	2207
2016 Q3	–	Sell	-681	Closed	-$43K	–	1521
2016 Q2	$43K	Buy	681 +16	+2%	+$2.63K	﹤0.01%	1558
2016 Q1	$154K	Sell	665 -61	-8%	-$14.8K	﹤0.01%	1465
2015 Q4	$231K	Buy	+726	New	+$197K	﹤0.01%	1456

Other funds holding ZVRA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return